Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.
Relating to health benefit plan coverage of prescription drugs for serious mental illnesses and opioid and substance use disorders.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to state overdose prevention and control efforts and the defense to prosecution for certain offenses involving possession of small amounts of controlled substances, marihuana, dangerous drugs, or abusable volatile chemicals, or possession of drug paraphernalia for defendants seeking assistance for a suspected overdose.
Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
Relating to an opioid-related drug overdose response protocol and training on the administration of an opioid antagonist for public school personnel.
Relating to the maintenance, administration, and disposal of opioid antagonists at school district campuses serving students in grades six and above.
Relating to the reporting of certain overdose information and the mapping of overdoses for public safety purposes.
Relating to the reporting of certain overdose information and the mapping of overdoses for public safety purposes.